Literature DB >> 6120976

Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells.

F Y Liew, C Hale, J G Howard.   

Abstract

Resistant CBA mice infected with Leishmania tropica promastigotes develop concomitant and convalescent immunity against reinfection. This can be adoptively transferred by splenic and lymph node T cells with a threshold dosage of 1 to 2.5 x 10(7). The effector cells are of Thy-1+, Lyt-1+2- phenotype. The same immune cell population also adoptively transfers specific DTH to L. tropica, which is restricted by the major histocompatibility complex. On the other hand, highly susceptible BALB/c mice infected with L. tropica develop antigen-specific suppressor T (Ts) cells (previously shown to inhibit the induction and expression of DTH), which are capable, on transference, of reversing the healing of lesions induced by prior sublethal irradiation of BALB/c mice. As few as 10(6) of these T cells are effective in abrogating the potent prophylactic effect of 550 rad. The Ts cells are of Thy-1+, Lyt-1+2-, and I-J- phenotype. Sublethally irradiated and infected BALB/c mice produce antibody responses quantitatively and isotypically similar during the critical first 40 days after infection whether or not they are injected with 10(7) Ts cells (nonhealing vs healing). Thus, impairment of DTH and curative immune responses in BALB/c mice cannot be attributed to a helper function of these Thy-1+, Lyt-1+2- cells for the formation of suppressive antibody.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6120976

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  Reduced numbers of CD4+ suppressor cells with subsequent expansion of CD8+ protective T cells as an explanation for the paradoxical state of enhanced resistance to Leishmania in T-cell deficient BALB/c mice.

Authors:  J O Hill
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

2.  Characterization of cellular immune response to chemically defined glycoconjugates from Leishmania mexicana subsp. amazonensis.

Authors:  M M Rodrigues; M T Xavier; L M Previato; M A Barcinski
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

3.  Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route.

Authors:  C A Power; G Wei; P A Bretscher
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

4.  Immunomodulatory effects of anti-CD4 antibody in host resistance against infections and tumors in human CD4 transgenic mice.

Authors:  D J Herzyk; E R Gore; R Polsky; K L Nadwodny; C C Maier; S Liu; T K Hart; A G Harmsen; P J Bugelski
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

5.  Novel 17-kilodalton Leishmania antigen revealed by immunochemical studies of a purified glycoprotein fraction recognized by murine T lymphocytes.

Authors:  M M Rodrigues; M T Xavier; L Mendonça-Previato; M A Barcinski
Journal:  Infect Immun       Date:  1988-07       Impact factor: 3.441

6.  Mechanisms associated with immunoregulation in human American cutaneous leishmaniasis.

Authors:  M Castés; A Agnelli; A J Rondón
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

7.  The cellular responses of tuberculosis and leprosy patients and of healthy controls in skin tests to 'new tuberculin' and leprosin A.

Authors:  J S Beck; S M Morley; J H Gibbs; R C Potts; M I Ilias; T Kardjito; J M Grange; J Stanford; R A Brown
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

8.  Restricted IgG isotype profiles in T. cruzi infected mice and Chagas' disease patients.

Authors:  M T Scott; M Goss-Sampson
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

9.  Expression of T-cell-associated serine proteinase 1 during murine Leishmania major infection correlates with susceptibility to disease.

Authors:  H Moll; C Müller; R Gillitzer; H Fuchs; M Röllinghoff; M M Simon; M D Kramer
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

10.  Demonstration of an indomethacin-sensitive mechanism regulating immune reactivity in American cutaneous leishmaniasis patients.

Authors:  M Castes; D Trujillo; D Scott; A J Rondon
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.